文献速递冠心病

血流储备分数与压力界限冠脉血流储备对冠心病结局的预测

Fractional flow reserve and pressure-bounded coronary flow reserve to predict outcomes in coronary artery disease.
PubMed 文献 · Eur Heart J · 2017-01-01

基于前瞻性多中心ICR-FFR注册研究,纳入1837例患者2088处病变,评估FFR与压力界限CFR(pb-CFR)对MACE的预测价值。中位随访1.9年,FFR≤0.80患者MACE发生率5.7% vs FFR>0.80患者2.8%(aHR 2.15,95%CI 1.19-3.89,P=0.011),而pb-CFR<2与≥2两组MACE发生率均为4.2%(aHR 0.98,95%CI 0.60-1.58,P=0.92)。加入pb-CFR未改善FFR对MACE的预测能力。

要点

  • FFR≤0.80患者MACE发生率5.7%,高于FFR>0.80患者的2.8%(aHR 2.15,P=0.011)。
  • pb-CFR<2与pb-CFR≥2两组MACE发生率均为4.2%,无显著差异(aHR 0.98,P=0.92)。
  • 加入pb-CFR未改善FFR对MACE的模型预测能力(global χ2 48.1-48.2,P>0.99)。

核心结论

  • 在这个纳入超过2000处冠脉病变的大型前瞻性注册研究中,FFR与临床结局强相关,而pb-CFR与临床事件之间未能确定显著关联,且加入pb-CFR知识未改善仅用FFR的预后判断。

研究设计与样本

  • 基于前瞻性多中心Interventional Cardiology Research Incooperation Society-FFR注册研究的亚组分析,共纳入1837例患者的2088处病变。
  • 根据基线和充血性压力阶差计算压力界限CFR(pb-CFR),将病变分为低值(<2)和高值(≥2)。
  • 主要终点为主要不良心脏事件(MACE,包括心源性死亡、心肌梗死和血运重建的复合终点),按患者水平分析。

主要发现

  • 中位随访1.9年(四分位距1.0-3.0年)期间,FFR≤0.80患者MACE发生率为5.7%,FFR>0.80患者为2.8%(aHR 2.15,95%CI 1.19-3.89,P=0.011)。
  • pb-CFR<2与pb-CFR≥2患者MACE发生率均为4.2%(aHR 0.98,95%CI 0.60-1.58,P=0.92)。
  • 加入FFR显著改善MACE模型预测(global χ2 38.8-48.1,P=0.002)。
  • 加入pb-CFR对结局分类无增量价值(global χ2 48.1-48.2,P>0.99)。

临床怎么用

  • 原文结论未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Fractional flow reserve (FFR) has proven to its prognostic and therapeutic value. However, the additive prognostic value of coronary flow reserve (CFR) remains unclear. This study sought to investigate the clinical utility of combined FFR and CFR measurements to predict outcomes. METHODS AND RESULTS: Using the prospective, multicentre Interventional Cardiology Research Incooperation Society-FFR registry, a total of 2088 lesions from 1837 patients were included in this substudy. Based on baseline and hyperaemic pressure gradients, we computed physiologic limits of CFR [the so called pressure-bounded (pb) CFR] and classified lesions as low (<2) or high (≥2). The primary endpoint was major adverse cardiac events (MACE, a composite of cardiac death, myocardial infarction, and revascularization) analysed on a per-patient basis. During a median follow-up of 1.9 years (inter-quartile range: 1.0-3.0 years), MACE occurred in 5.7% of patients with FFR ≤0.80 vs. 2.8% of patients with FFR >0.80 [adjusted hazard ratio (aHR): 2.15, 95% confidence interval (CI): 1.19-3.89; P = 0.011. In contrast, the incidence of MACE did not differ between patients with pb-CFR < 2 vs. pb-CFR ≥ 2 (4.2% vs. 4.2%; aHR: 0.98, CI: 0.60 to 1.58; P = 0.92). Incorporation of FFR significantly improved model prediction of MACE (global χ2 38.8-48.1, P = 0.002). However, pb-CFR demonstrated no incremental utility to classify outcomes (global χ2 48.1-48.2, P > 0.99). CONCLUSIONS: In this large, prospective registry of over 2000 coronary lesions, FFR was strongly associated with clinical outcomes. In contrast, a significant association between pb-CFR and clinical events could not be determined and adding knowledge of pb-CFR did not improve prognostication over FFR alone.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Ahn JM, Zimmermann FM, Johnson NP, et al. Fractional flow reserve and pressure-bounded coronary flow reserve to predict outcomes in coronary artery disease. Eur Heart J. 2017. PMID: 28419280. doi:10.1093/eurheartj/ehx139

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。